EMPAPHAGE-M 12.5+500MG 14S TABEmpaphage M is a combination therapy for type 2 diabetes containing Empagliflozin 12. 5 mg (an SGLT 2 inhibitor) and Metformin 500 mg (a biguanide). It helps lower blood glucose by increasing glucose excretion through urine and improving the bodys response to insulin. It supports long term blood sugar control while offering added benefits for cardiovascular and kidney health in diabetes patients. Uses Helps control Type 2 Diabetes Mellitus. Used when